Business Description
M3 Inc
ISIN : JP3435750009
Compare
Compare
Traded in other countries / regions
2413.JapanMTHRY.USA4YC.Germany2413.Mexico IPO Date
2024-06-26Description
M3 Inc is a Japan-based company engaged in providing medical-related services through the use of the Internet. It also supports marketing of pharmaceutical companies and medical equipment manufacturers. The company's business segment includes, Medical Portal segment, Evidence Solution segment, Overseas segment, Clinical Platform segment, Sales Platform segment, and Others. The company generates the majority of its revenue from Medical Portal segment.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.36 | |||||
| Equity-to-Asset | 0.71 | |||||
| Debt-to-Equity | 0.07 | |||||
| Debt-to-EBITDA | 0.37 | |||||
| Interest Coverage | 35.76 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 6.57 | |||||
| Beneish M-Score | -2.44 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 12.2 | |||||
| 3-Year EBITDA Growth Rate | 6.8 | |||||
| 3-Year EPS without NRI Growth Rate | 6.2 | |||||
| 3-Year FCF Growth Rate | 4.3 | |||||
| 3-Year Book Growth Rate | 20.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 6.36 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 12.72 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.41 | |||||
| 9-Day RSI | 28.98 | |||||
| 14-Day RSI | 35.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.72 | |||||
| Quick Ratio | 3.72 | |||||
| Cash Ratio | 2.8 | |||||
| Days Sales Outstanding | 76.56 | |||||
| Days Payable | 126.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | 20.5 | |||||
| Shareholder Yield % | -0.76 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 57.52 | |||||
| Operating Margin % | 22.76 | |||||
| Net Margin % | 15.8 | |||||
| FCF Margin % | 17.16 | |||||
| ROE % | 11.43 | |||||
| ROA % | 8.21 | |||||
| ROIC % | 15.26 | |||||
| 3-Year ROIIC % | 2.38 | |||||
| ROC (Joel Greenblatt) % | 233.85 | |||||
| ROCE % | 15.04 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 24.18 | |||||
| Forward PE Ratio | 20.98 | |||||
| PE Ratio without NRI | 24.18 | |||||
| Shiller PE Ratio | 28.46 | |||||
| Price-to-Owner-Earnings | 22.18 | |||||
| PEG Ratio | 1.12 | |||||
| PS Ratio | 3.82 | |||||
| PB Ratio | 2.71 | |||||
| Price-to-Tangible-Book | 4.67 | |||||
| Price-to-Free-Cash-Flow | 22.47 | |||||
| Price-to-Operating-Cash-Flow | 20.41 | |||||
| EV-to-EBIT | 12.71 | |||||
| EV-to-EBITDA | 11.82 | |||||
| EV-to-Revenue | 3.19 | |||||
| EV-to-FCF | 18.77 | |||||
| Price-to-Projected-FCF | 1.14 | |||||
| Price-to-DCF (Earnings Based) | 0.51 | |||||
| Price-to-DCF (FCF Based) | 0.46 | |||||
| Price-to-Median-PS-Value | 0.26 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.57 | |||||
| Price-to-Graham-Number | 2.24 | |||||
| Price-to-Net-Current-Asset-Value | 9.77 | |||||
| Price-to-Net-Cash | 24.71 | |||||
| Earnings Yield (Greenblatt) % | 7.87 | |||||
| FCF Yield % | 4.45 | |||||
| Forward Rate of Return (Yacktman) % | 19.76 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
M3 Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1,530.19 | ||
| EPS (TTM) (€) | 0.355 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 35.04 | ||
| 14-Day ATR (€) | 0.279876 | ||
| 20-Day SMA (€) | 9.765 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 7.05 - 10.9 | ||
| Shares Outstanding (Mil) | 679.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
M3 Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
M3 Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
M3 Inc Frequently Asked Questions
What is M3 Inc(STU:4YC)'s stock price today?
The current price of STU:4YC is €8.40. The 52 week high of STU:4YC is €10.90 and 52 week low is €7.05.
When is next earnings date of M3 Inc(STU:4YC)?
The next earnings date of M3 Inc(STU:4YC) is .
Does M3 Inc(STU:4YC) pay dividends? If so, how much?
M3 Inc(STU:4YC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers